Literature DB >> 1757929

Mortality predictors among 263 patients with rheumatoid arthritis.

J P Leigh1, J F Fries.   

Abstract

A cohort of 263 patients who completed Health Assessment Questionnaires (HAQ) each year from 1981 to 1989 is examined. Forty-three (43) possible covariates measured in 1981 are considered that might help predict mortality over the 8 years of the study. We use univariate correlation coefficients, stepwise regressions, and survival functions to identify a number of covariates that appear useful for predicting survival: age (-), prednisone use (-), disability index (-), male sex (-), never married (-), penicillamine use (+), divorced (+), and no occupation (-). Our results confirm studies suggesting that the HAQ disability index is a useful prognosticator of length of survival.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757929

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Quality of life measures in health care. I: Applications and issues in assessment.

Authors:  R Fitzpatrick; A Fletcher; S Gore; D Jones; D Spiegelhalter; D Cox
Journal:  BMJ       Date:  1992-10-31

2.  Hearing, mobility, and pain predict mortality: a longitudinal population-based study.

Authors:  David Feeny; Nathalie Huguet; Bentson H McFarland; Mark S Kaplan; Heather Orpana; Elizabeth Eckstrom
Journal:  J Clin Epidemiol       Date:  2012-04-20       Impact factor: 6.437

3.  No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.

Authors:  E J Kroot; M A van Leeuwen; M H van Rijswijk; M L Prevoo; M A Van 't Hof; L B van De Putte; P L van Riel
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

4.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

5.  Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass.

Authors:  Jon T Giles; Susan J Bartlett; Ross E Andersen; Kevin R Fontaine; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2008-10-15

6.  Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study.

Authors:  R Munro; R Hampson; A McEntegart; E A Thomson; R Madhok; H Capell
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

Review 7.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

8.  Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007.

Authors:  Ashima Makol; John M Davis; Cynthia S Crowson; Terry M Therneau; Sherine E Gabriel; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

9.  Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years.

Authors:  E Wagner; K Ammer; G Kolarz; I Krajnc; E Palkonyai; O Scherak; C Schödl; F Singer; P Temesvari; A Wottawa
Journal:  Rheumatol Int       Date:  2007-04-11       Impact factor: 2.631

10.  Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.

Authors:  John H Kempen; Ebenezer Daniel; James P Dunn; C Stephen Foster; Sapna Gangaputra; Asaf Hanish; Kathy J Helzlsouer; Douglas A Jabs; R Oktay Kaçmaz; Grace A Levy-Clarke; Teresa L Liesegang; Craig W Newcomb; Robert B Nussenblatt; Siddharth S Pujari; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  BMJ       Date:  2009-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.